Hypothesis

Inherited mitochondrial DNA (mtDNA) haplotype sets the baseline for mitonuclear communication that shapes the epigenetic landscape of the nucleus and modulates chronic innate immune activation; haplotypes that are mismatched with the nuclear genome trigger persistent cGAS‑STING signaling, driving epigenetic drift and inflammaging, whereas compatible haplotypes maintain a protective retrograde signal that preserves nuclear epigenome integrity and extends lifespan.

Rationale

• Somatic mtDNA mutations accumulate with age but, as shown in wild‑type mice, equivalent mutation loads do not impair respiratory function [3], suggesting that the sequence of the mtDNA genome—not just its damage load—is the critical variable.
• Conplastic studies demonstrate that mtDNA haplotype alone can alter metabolism, ROS production, insulin signaling, telomere length, and lifespan [4], indicating a strong influence of the inherited mitochondrial genome on nuclear‑regulated phenotypes.
• The nucleus encodes ~1,100 mitochondrial proteins [6], creating a tight co‑adaptation requirement; mismatched mtDNA‑nDNA pairs likely generate proteostatic stress and release of mtDNA fragments into the cytosol.
• Cytosolic mtDNA activates the cGAS‑STING pathway, a known driver of sterile inflammation and age‑related pathology [5]; chronic STING signaling can alter histone modifications and DNA methylation through downstream IFN‑STING‑IRF3 signaling, promoting epigenetic drift.

Novel Mechanistic Insight

We propose that specific mtDNA haplotypes modulate the efficiency of mitochondrial antiviral signaling (MAVS) and the release of oxidised mtDNA fragments, thereby tuning the amplitude of cGAS‑STING activation. Haplotypes that produce less oxidised mtDNA or promote tighter coupling with nuclear‑encoded mitochondrial chaperones (e.g., HSP60, HSP10) limit cytosolic mtDNA, reducing STING activation. Consequently, the nucleus experiences lower IFN‑stimulated gene expression, preserving DNA methyltransferase activity and histone acetylation patterns that sustain youthful gene expression programs. Conversely, mismatched haplotypes increase oxidised mtDNA efflux, hyperactivate STING, and drive a chronic interferon‑responsive epigenome that accelerates aging.

Testable Predictions

1. Epigenetic Signature: Conplastic mice with mismatched mtDNA‑nDNA pairs will show heightened IFN‑stimulated gene expression, increased cytosolic mtDNA, and a distinct DNA methylation drift (e.g., loss of methylation at CpG islands of senescence‑associated secretory phenotype genes) compared with matched pairs, even when total mtDNA mutation load is equivalent.
2. Rescue via STING Inhibition: Pharmacological or genetic inhibition of STING in mismatched conplastic mice will normalize the epigenetic drift, reduce inflammaging markers (IL‑6, TNF‑α), and extend median lifespan to levels comparable with matched pairs.
3. Haplotype‑Specific Chaperone Overexpression: Overexpressing the nuclear‑encoded mitochondrial chaperone HSP60 in mismatched mice will decrease cytosolic mtDNA, attenuate STING signaling, improve mitochondrial proteostasis, and extend lifespan without altering mtDNA mutation rates.
4. Human Correlate: In human cohorts, individuals carrying mtDNA haplogroups associated with longevity (e.g., haplogroup J) will exhibit lower circulating cell‑free mtDNA, reduced STING pathway activation in peripheral blood mononuclear cells, and a slower epigenetic aging clock (e.g., Horvath’s DNAmAge) than those with haplogroups linked to shorter lifespan, after controlling for nuclear ancestry.

Falsifiability

If mismatched conplastic mice do not exhibit elevated cytosolic mtDNA or STING activation relative to matched controls, or if STING inhibition fails to rescue epigenetic drift and lifespan, the hypothesis would be falsified. Similarly, if human mtDNA haplogroups show no correlation with circulating mtDNA, STING signaling, or epigenetic age after adjusting for population stratification, the proposed mechanism would not hold.